Document Type : Short communication
Author
Department of Nuclear Medicine, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey
Abstract
Keywords
Main Subjects
Sharma M, Aronow MS, Patel L, Gandhi K, Desai H. Hyperthyroidism. Med Sci Monit. 2011; 17(4): 85-91
Gilbert J.Thyrotoxicosis – investigation and management.Clinical Medicine. 2017; 17( 3): 274–7.
Cooper DS. Hyperthyroidism. The Lancet. 2003; 362: 459-68.
Maısey MN, Natarajan T K, Hurley PJ, Wagner HN. Validation of a Rapid Computerized Method of Measuring 99mTc Pertechnetate Uptake for Routine Assessment of Thyroid Structure and Function. J Clin Endocrinol Metab. 1973; 36: 317-22.
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.Thyroıd. 2016; 26(10): 1343-421.
McGill PE, Harden RM, Robertson IW, Shimmins J. comparison between the uptake of Technetium-99m and Iodine-131 by the thyroid gland.Journal of Endocrinology. 1971; 49(3):531-6l
Macauley M, Shawgi M, Ali T, Curry A, Howe K, Howell B, et al.Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a single centre UK population. Nucl Med Commun. 2018; 39(9):834-8.
Beindorff N, Bartelheimer A, Huang K, Lukas M, Lange C, Huang EL, et al.Normal Values of Thyroid Uptake of 99mTechnetium Pertechnetate SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm. Nuklearmedizin. 2018; 57(5):181-9.
Singhal N, Praveen VP, Bhavani N, Menon AS, Menon U, Abraham N, et al. Technetium uptake predicts remission and relapse in Grave’s disease patients on antithyroid drugs for at least 1 year in South Indian subjects.Indian J Endocrinol Metab. 2016; 20(2): 157–61.
Baskaran C, Misra M, Levitsky LL. Diagnosis of Pediatric Hyperthyroidism: Technetium 99 Uptake Versus Thyroid Stimulating Immunoglobulins. THYROID. 2015; 25(1): 37-41.
Uchida T, Suzuki R, i Kasai T, Onose H, Komiya K, Goto H, et al. Cutoff value of thyroid uptake of 99mTc-pertechnetate to discriminate between Graves’ disease and painless thyroiditis: a single center retrospective study. Endocr J. 2016;63(2):143-9.